Mainz Biomed N.V. (MYNZ) Financials
MYNZ Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2024-03-31 | 15.4 million | 12.2 million |
| 2023-12-31 | 15.4 million | 12.2 million |
| 2023-09-30 | 17.9 million | 14.5 million |
| 2023-06-30 | 19.3 million | 14.1 million |
MYNZ Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2024-03-31 | -4.9 million | 818991 |
| 2023-12-31 | -4.9 million | 818991 |
| 2023-09-30 | -6.6 million | 1.1 million |
| 2023-06-30 | -5.2 million | 1.2 million |
MYNZ Net Income
No data available :(
MYNZ Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2024-03-31 | 7.1 million | - | - |
| 2023-12-31 | - | - | 1.5 million |
| 2023-09-30 | 9.3 million | - | 1.9 million |
| 2023-06-30 | 10.9 million | - | 2.0 million |
MYNZ Shares Outstanding
MYNZ Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2024-03-31 | 261808 | 2.0 million | 3.5 million | 1.2 million |
| 2023-12-31 | 261808 | 2.0 million | 4.8 million | - |
| 2023-09-30 | 112478 | 1.9 million | 2.8 million | 1.1 million |
| 2023-06-30 | 123625 | 3.5 million | 2.8 million | 1.8 million |
MYNZ Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2024-03-31 | 214761 | 80027 |
| 2023-12-31 | 214761 | 80027 |
| 2023-09-30 | 181669 | 94483 |
| 2023-06-30 | 248945 | 100147 |
MYNZ
Price: $0.74
52 week price:
Earnings Per Share: -1.62 USD
P/E Ratio: -0.53
Exchange: NCM
Sector: Healthcare
Industry: Diagnostics & Research
Volume: 15400
Market Capitalization: 12.5 million